These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 17679618)

  • 21. Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.
    Cai C; Chen SY; Zheng Z; Omwancha J; Lin MF; Balk SP; Shemshedini L
    Oncogene; 2007 Mar; 26(11):1606-15. PubMed ID: 16964290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.
    Weissmann N; Hackemack S; Dahal BK; Pullamsetti SS; Savai R; Mittal M; Fuchs B; Medebach T; Dumitrascu R; Eickels Mv; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L658-65. PubMed ID: 19617308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.
    Neo BH; Kandhi S; Wolin MS
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2295-304. PubMed ID: 21926339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
    Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.
    Zhao L; Mason NA; Strange JW; Walker H; Wilkins MR
    Circulation; 2003 Jan; 107(2):234-7. PubMed ID: 12538421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
    de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.
    Groneberg D; König P; Wirth A; Offermanns S; Koesling D; Friebe A
    Circulation; 2010 Jan; 121(3):401-9. PubMed ID: 20065162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.
    Durgin BG; Wood KC; Hahn SA; McMahon B; Baust JJ; Straub AC
    J Mol Cell Cardiol; 2022 Jan; 162():72-80. PubMed ID: 34536439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Dasgupta A; Bowman L; D'Arsigny CL; Archer SL
    Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil inhibits hypoxia-induced pulmonary hypertension.
    Zhao L; Mason NA; Morrell NW; Kojonazarov B; Sadykov A; Maripov A; Mirrakhimov MM; Aldashev A; Wilkins MR
    Circulation; 2001 Jul; 104(4):424-8. PubMed ID: 11468204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
    Bachiller PR; Cornog KH; Kato R; Buys ES; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L569-81. PubMed ID: 23934926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders.
    Wilkins MR; Aldashev AA; Wharton J; Rhodes CJ; Vandrovcova J; Kasperaviciute D; Bhosle SG; Mueller M; Geschka S; Rison S; Kojonazarov B; Morrell NW; Neidhardt I; Surmeli NB; Aitman TJ; Stasch JP; Behrends S; Marletta MA
    Circ Cardiovasc Genet; 2014 Dec; 7(6):920-9. PubMed ID: 25373139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
    Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.